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Introduction {#sec1}
============

Lineage conversion, where one terminally differentiated cell is converted into another terminally differentiated cell type via viral-mediated expression of transcription factors, has recently been achieved for many cell types ([@bib20]), including cells of the CNS such as neurons, astrocytes, oligodendrocytes, and neural progenitor cells ([@bib7; @bib18; @bib21; @bib26]). In the brain, resident glia and transiently appearing proliferating progenitors have been successfully converted into neurons or neural progenitor cells in situ using defined combinations of transcription factors ([@bib10; @bib19]), and in some cases, functional properties such as action potentials and/or postsynaptic currents have been observed ([@bib12; @bib15]). However, to date, it is not clear if the new neurons can integrate into the host neuronal circuitry, and studies of this are partly hampered by lack of good experimental systems.

In this study, we present an adeno-associated virus (AAV)-based conversion system that can be used to specifically target and convert resident glia at high efficiency. When combined with a neuron-specific reporter system, it allows for long-term monitoring and functional analysis of the reprogrammed neurons. Using this system, we show that the striatal NG2 glia can be converted to GABAergic and glutamatergic neurons that remain stable over a long period of time and display electrophysiological properties of functional neurons. By combining the reporter system with virus-based tracing methodology, we show that the new neurons integrate into local circuitry in an efficient manner.

Results {#sec2}
=======

To specifically target *NG2*-expressing cells, we developed Cre-recombinase-dependent AAV vectors. In these flip-excision (FLEX) vectors, the conversion factors and reporter genes are inserted in an antisense direction, flanked by two pairs of antiparallel, heterotypic *loxP* sites ([@bib3]). Each of the three conversion factors, *Ascl1*, *Lmx1a*, and *Nurr1* (ALN), are placed under the control of the ubiquitous chicken β-actin (cba) promoter on individual vectors ([Figure S1](#mmc1){ref-type="supplementary-material"}A). To construct a reporter system that restricts GFP expression to reprogrammed neurons, we placed GFP under the control of the neuron-specific synapsin promoter in a FLEX vector ([Figure S1](#mmc1){ref-type="supplementary-material"}A) so that GFP would expressed only in neurons originating from a Cre-expressing cell.

To validate the vectors, we first transfected T293 cells and transduced the cultures with a lentiviral vector expressing Cre. In the absence of Cre, there is no transgene expression. In the presence of Cre, the transgene is excised and recombined stably in a correctly reinserted orientation, allowing the transgene to be transcribed and protein to be expressed ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Next, we injected our vectors into the striatum of transgenic mice aged 12--16 weeks ([Figure 1](#fig1){ref-type="fig"}A) that express Cre under the control of the mouse *NG2* (*Cspg4*) promoter/enhancer ([@bib27]). When injecting a ubiquitous reporter vector (cba-GFP, n = 5; [Figure S1](#mmc1){ref-type="supplementary-material"}A) that expresses GFP in all Cre-positive cells, we found that GFP was exclusively expressed in NG2 glia and co-localized with NG2 ([Figure 1](#fig1){ref-type="fig"}C), SOX10, and PDGFRα ([Figures S1](#mmc1){ref-type="supplementary-material"}F and S1G). When we injected our new neuron-specific reporter (syn-GFP) into the striatum of *NG2*-cre-expressing mice aged 12--16 weeks, we did not detect any GFP-expressing cells ([Figure 1](#fig1){ref-type="fig"}B), with the exception of 1 animal out of 11 analyzed, where we observed a total of 18 GFP^+^ cells. We also injected the cba-GFP and syn-GFP vectors into wild-type mice and never detected any GFP expression ([Figure S1](#mmc1){ref-type="supplementary-material"}C; n = 10 for each reporter). Taken together, these data confirm a specific Cre-dependent control of gene expression only in NG2-expressing cells in vivo and establish that the neuron-specific reporter is not active in these cells. All subsequent experiments were performed in mice aged 12--16 weeks; we included control animals injected with syn-GFP only in each experiment and never observed any conversion in these animals ([Figures 1](#fig1){ref-type="fig"}G and 1I).

To analyze the potential for neural conversion of striatal NG2 glia using ALN as conversion factors, we injected a mix of ALN and syn-GFP (1:1:1:1) into the striatum of *NG2*-Cre mice and also injected syn-GFP alone as control (n ≥ 4 for each time point and vector combination). Animals were sacrificed 2 days and 1, 4, and 12 weeks after vector injections. In the ALN-injected group, no GFP-positive cells could be detected when analyzed after 2 days of injection (n = 4, not shown), and only a few GFP-positive cells could be detected when analyzed 1 week after injection (n = 6; [Figures 1](#fig1){ref-type="fig"}D and 1D′). The number of GFP-positive cells increased by 4 and 12 weeks (n = 4 and 7 for each time point, respectively; [Figures 1](#fig1){ref-type="fig"}E, 1E′, 1F, and 1F′). No GFP-expressing cells could be detected in the control-injected animals ([Figures 1](#fig1){ref-type="fig"}G, [S1](#mmc1){ref-type="supplementary-material"}D, and S1E). Quantifications showed an increasing number of converted GFP^+^ cells over time, reaching 6,912 ± 3,052 per animal at 4 weeks (n = 3). As Ascl1 alone can convert somatic cells into neurons whereas Lmx1a and Nurr1 cannot ([@bib8; @bib16]), we next performed injections with Ascl1 only and compared these mice with ALN-injected and control animals. We found some converted neurons in the Ascl1-only group ([Figure 1](#fig1){ref-type="fig"}H), albeit in much lower numbers compared to ALN-injected animals ([Figure 1](#fig1){ref-type="fig"}I). The control animals injected with syn-GFP only did not contain any reprogrammed neurons ([Figure 1](#fig1){ref-type="fig"}I).

To establish a neuronal phenotype of the ALN-converted cells, we stained for the neuronal marker NeuN. The GFP^+^ cells co-expressed NeuN ([Figures 2](#fig2){ref-type="fig"}A--2A′′), and the proportion of converted cells co-expressing GFP and NeuN increased from 20.8% ± 5.9% (n = 3) at 4 weeks to 46.8% ± 2.9% (n = 3) after 12 weeks ([Figure 2](#fig2){ref-type="fig"}B). The reprogrammed cells also co-expressed MAP2, and confocal analysis confirmed the presence of cells positive for syn-GFP, NeuN, and MAP2, further confirming a mature neuronal phenotype of the converted cells ([Figures 2](#fig2){ref-type="fig"}C--2C′′′). Staining for NG2 and GFP confirmed that no cells co-expressed GFP and NG2, suggesting a rapid loss of glial properties in the converted cells ([Figures 2](#fig2){ref-type="fig"}D--2D′′).

Next, we co-stained GFP with a panel of subtype-specific markers: tyrosine hydroxylase (TH) for dopaminergic neurons, GAD65/67 for GABAergic neurons, vGlut1 for glutamatergic neurons, DARPP32 for striatal projection neurons, and paravalbumin (PA), calbindin (CALB), and choline acetyltransferase (Chat) for striatal interneurons. The gene combination used in this study (ALN) has been shown to convert mouse fibroblasts into functional neurons, including dopamine neurons, in vitro ([@bib6]). However, we did not detect any converted neurons expressing TH, even though ALN was used to drive neural conversion in vivo ([Figure S2](#mmc1){ref-type="supplementary-material"}F). Given that all factors were delivered on separate vectors, the lack of TH could potentially be explained by lack of co-expression of the dopamine fate determinants in the reprogrammed neurons. However, when analyzing this, we found a large overlap in expression when staining for GFP and NURR1 as well as for GFP and LMX1A ([Figures S1](#mmc1){ref-type="supplementary-material"}H--S1I′′). Quantifications showed that 79% ± 8% and 83.7% ± 6% of the GFP+ neurons co-expressed LMX1A and NURR1, respectively. To exclude that the lack of a dopamine-like phenotype is due to the cell of origin, we repeated the experiment using astrocytes instead of NG2 glia as a starter population for neural conversion. In these studies, we used a *GFAP*-Cre mouse to specifically target the resident astrocyte population. We injected syn-ALN and syn-GFP into the striatum of *GFAP*-Cre mice as well as syn-GFP only (n = 5 for each group). 6 weeks after vector injections, we could detect a high level of neural conversion as assessed by GFP expression ([Figure S2](#mmc1){ref-type="supplementary-material"}F) in the animals injected with ALN, but not in animals injected with syp-GFP alone, matching what we have reported from reprogramming *GFAP*-Cre glia using Ascl1, Brn2a, and Mytl1 ([@bib19]). Co-staining with TH showed that the ALN-converted neurons originating from GFAP^+^ astrocytes, like the ALN-converted neurons originating from NG2^+^ glia, do not express TH ([Figure S2](#mmc1){ref-type="supplementary-material"}F). 16% of the reprogrammed neurons expressed vGlut1 ([Figure 2](#fig2){ref-type="fig"}E), and 68% expressed GAD65/67 ([Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}A), while none were found to co-express DARPP32, PA, CALB, or CHAT ([Figures S2](#mmc1){ref-type="supplementary-material"}B--S2E).

Twelve weeks after conversion, the reprogrammed neurons had acquired a mature neuronal morphology, and dendritic spine-like protrusions could be observed ([Figure 3](#fig3){ref-type="fig"}A). At this time point, we used patch-clamp electrophysiology to investigate the functional properties of the neurons obtained ([Figure 3](#fig3){ref-type="fig"}B). All the GFP-expressing neurons recorded showed functional electrophysiological properties of neurons, with a resting membrane potential (V~0~) of −61.4 ± 9.7 mV (n = 5) and the ability to evoke repetitive action potentials after current injections, with a mean amplitude of 33.5 ± 2.29 mV and an action potential threshold of 25 ± 7.19 pA ([Figure 3](#fig3){ref-type="fig"}C; [Table S1](#mmc1){ref-type="supplementary-material"}; n = 6). Furthermore, all the converted cells recorded from showed fast-inactivated inward and outward currents characteristic of sodium and delayed-rectifier potassium currents, with a peak amplitude of *I*~Na~ at 625 ± 131 pA and *I*~K~ at 2,020 ± 290 pA ([Figure 3](#fig3){ref-type="fig"}D; n = 6). Both action potentials and inward currents could be blocked with the neurotoxin tetrodotoxin (TTX) ([Figure 3](#fig3){ref-type="fig"}E). We could also detect post-synaptic events with a mean frequency of 3.67 ± 1.93 Hz and a peak amplitude of 5.03 ± 0.64 pA, indicative of formation of a functional postsynaptic compartment and possible establishment of synaptic networks ([Figure 3](#fig3){ref-type="fig"}F; [Table S1](#mmc1){ref-type="supplementary-material"}).

Functional neuronal properties, including post-synaptic events, have previously been described for in-vivo-reprogrammed striatal astrocytes and for reprogrammed cortical NG2 glia ([@bib12; @bib15]), but these types of recordings cannot distinguish between functional integration with host neurons and communication among reprogrammed neurons. To confirm circuitry integration, and to map what neurons form synaptic inputs to the newly reprogrammed cells, we used modified rabies virus (ΔG-rabies) to trace connectivity of the reprogrammed neurons. ΔG-rabies is a deletion mutant virus where the gene coding for glycoprotein (GP; necessary for transsynaptic spread) is replaced by the gene coding for mCherry ([@bib24; @bib25]) and pseudotyped to infect cells only via the avian tva receptor ([@bib4]). To selectively trace connectivity of our in-vivo-reprogrammed neurons, we constructed a FLEX tracing vector with a tricistronic construct encoding for nuclear GFP (ncGFP), tva receptor, and rabies GP under the synapsin promoter ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Expression of this vector is exclusive to the reprogrammed neurons and renders them infectable with Δrabies via the tva receptor. Since the reprogrammed neurons also express GP from the tracing construct, the rabies can assemble into infectious particles in the reprogrammed neurons and transmit mCherry retrogradely across one synapse to host neurons that provide efferent input. Thus, targeted reprogrammed neurons (starter neurons) will appear red and green, while traced host neurons that synapse onto the starter neurons appear red only (schematic in [Figure 4](#fig4){ref-type="fig"}A). As a positive control, we used injection of unflexed tracing vectors containing the same synapsin-driven tricistronic construct with ncGFP, tva, and GP ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Because it is not FLEXed, this vector infects host neurons and thus traces the connectivity of endogenous striatal cells. We also injected animals with a vector containing ncGFP and tva but lacking GP ([Figure S3](#mmc1){ref-type="supplementary-material"}B). This control vector allows for Δrabies infection via the tva receptor but no transsynaptic spreading, as the cell lacks GP ([@bib24]).

Three groups of animals were injected with (1) unflexed tracing vector as a positive control (tracer-control), (2) flexed tracing vector together with ALN to trace connectivity of reprogrammed cells (FLEX tracer + ALN), and (3) control vector lacking GP. 12 weeks after injection of these tracing and control vectors, Δrabies was injected in the same area, and 1 week later, the animals were perfused and used for histology ([Figure 4](#fig4){ref-type="fig"}B). In animals injected with tracer control (that traces from endogenous neurons), we could detect targeted host starter cells expressing GFP and mCherry at the injection site ([Figure 4](#fig4){ref-type="fig"}C), as well as traced-red-only cells (i.e., striatal neurons that have made a synaptic contact with the targeted cells) ([Figure 4](#fig4){ref-type="fig"}C). Outside the striatum, we could also detect traced mCherry^+^/GFP^−^ neurons in structures that normally innervate the striatum, such as the motor cortex ([Figure 4](#fig4){ref-type="fig"}D), thalamus ([Figure 4](#fig4){ref-type="fig"}E), and substantia nigra ([Figure 4](#fig4){ref-type="fig"}F). In the animals injected with control vector lacking GP, no tracing was observed ([Figure S3](#mmc1){ref-type="supplementary-material"}C), confirming the transsynaptic spread of mCherry.

To trace connectivity of the reprogrammed neurons, animals were injected with the FLEX tracer vector in combination with ALN ([Figure 4](#fig4){ref-type="fig"}B). In these animals, we detected targeted reprogrammed starter cells expressing GFP and mCherry at the injection site ([Figure 4](#fig4){ref-type="fig"}G). Also in this group, red-only-traced cells representing endogenous host neurons that have made a synaptic contact with the reprogrammed neurons could be detected ([Figure 4](#fig4){ref-type="fig"}G). Co-staining of mCherry with DARPP32 showed that host cells that connect with the reprogrammed neurons are of the medium spiny neuron subtype ([Figures 4](#fig4){ref-type="fig"}K--4K′′). Interestingly, no mCherry-positive neurons could be detected outside the striatum in this group, indicating that the new neurons preferentially integrate into local circuitry ([Figures 4](#fig4){ref-type="fig"}H--4J).

The starter neurons and the traced neurons were evenly distributed within the striatum ([Figure 4](#fig4){ref-type="fig"}L). Quantifications of the reprogrammed starter neurons and the traced host neurons showed that each animal contained more traced host neurons than reprogrammed starter neurons ([Figure 4](#fig4){ref-type="fig"}M) and that, on average, each reprogrammed neuron was contacted by three or four host neurons ([Figure 4](#fig4){ref-type="fig"}N).

Discussion {#sec3}
==========

Recent studies have shown that it is possible to convert endogenous glia into functional neurons in vivo, which offers new possibilities for brain repair ([@bib2]). With few exceptions ([@bib12; @bib15]), the neuronal properties of the in-vivo-reprogrammed neurons have mostly been assessed based on marker expression ([@bib10; @bib13; @bib19]) or in vitro ([@bib10]).

In this study, we have developed an AAV-based vector system for in vivo neural conversion that results in efficient targeting and conversion of glia in situ. Importantly, the reporters used in this system are designed to be exclusive to the newly reprogrammed neurons and remain stable over time, allowing for long-term analysis of phenotype and function of the new neurons. The reporter can be combined with virus-based tracing methodology, which permits mapping of circuitry integration and allows for the precise identification of the source of host afferent inputs to the reprogrammed neurons.

The vector combination used in this study (ALN) has previously been used to reprogram mouse fibroblasts and glia into dopamine neurons in vitro ([@bib1; @bib6; @bib19]), yet no TH-expressing neurons could be detected when astrocytes or NG2 glia were converted in vivo. This mimics previous findings on astrocyte conversion, where several factors have been shown to convert astrocytes into neurons in vitro ([@bib5; @bib11]) yet fail to do so in vivo ([@bib17]).

Nevertheless, the use of ALN results in functionally mature neurons in larger proportions than previously reported for conversion of resident glia using Sox2 alone or in combination with Mash1 ([@bib12]), without the need for treatment with neurotrophic factors or histone deacetylase inhibitor as previously reported as a requirement for neuronal maturation ([@bib15]). We made use of a monosynaptic tracing methodology based on modified rabies virus to analyze if and how the new reprogrammed neurons integrate with existing host neurons. Rabies-based tracing has previously been used to trace connectivity of endogenous neural circuitry ([@bib14; @bib23]), as well as newly born neurons in the olfactory bulb and hippocampus ([@bib9; @bib22]). Here, we used it to map efferent connectivity to the newly reprogrammed neurons and revealed that they are extensively innervated by host striatal projection neurons.

Experimental Procedures {#sec4}
=======================

Animals and Surgery {#sec4.1}
-------------------

All experimental procedures were carried under the European Union Directive (2010/63/EU) and approved by the ethical committee for the use of laboratory animals at Lund University and the Swedish Department of Agriculture (Jordbruksverket). Surgery was performed under general anesthesia using 2% isoflurane in a mix of air an N~2~O at a 4:1 ratio. For conversion, 1 μl vector was injected in the striatum of each animal at a rate of 0.2 μl/min and a diffusion time of 2 min at the coordinates A/p = +0.5, M/L = −2.0, and D/V = −2.7, toothbar = flat. For tracing experiments, tracing vectors plus ALN were injected at the same dilutions and volume as above at the same coordinates, and tracing vector alone was injected contra-laterally (M/L 2.0). Animals were kept for 11 weeks, and 1 week prior to perfusion, animals were injected with ΔG-rabies diluted to 5% of stock (20--30 × 10^6^ TU/ml) in three consecutive injections of two deposits each (0.5 μl/deposit) flanking the original injection at coordinates (1) A/P +1.4; M/L −2.0; (2) A/P +0.4; M/L −2.0; or (3) A/P 0.9; M/L −1.5. A depth of D/V −3 and −2 was used for all sites.

Patch-clamp electrophysiology was performed on coronal brain slices at 12 weeks post-conversion. Mice were killed by decapitation, and brains were rapidly taken out and cut on a vibratome at 300 μm. Slices were transferred to a recording chamber and submerged in a continuously flowing Krebs solution gassed with 95% O~2~ and 5% CO~2~ at 28°C. The composition of the standard solution was 126 mM NaCl, 2.5 mM KCl, 1.2 mM NaH~2~PO~4~-H~2~O, 1.3 mM MgCl~2~-6H~2~O, and 2.4 mM CaCl~2~-6H~2~O. Voltage-gated sodium channels were blocked with 1 μM TTX (Tocris). Recordings were made using Multiclamp 700B (Molecular Devices), and signals were acquired at 10 kHz using pClamp10 software and a data acquisition unit (Digidata 1440A, Molecular Devices). Input resistances and injected currents were monitored throughout the experiments.

Converted cells were identified with their GFP fluorescence and patched with borosilicate glass pipettes (3--7 MOhm) filled with the following intracellular solution: 122.5 mM potassium gluconate, 12.5 mM KCl, 0.2 mM EGTA, 10 mM HEPES, 2 mM MgATP, 0.3 mM Na~3~GTP, and 8 mM NaCl adjusted to pH 7.3 with KOH. Resting membrane potentials were monitored immediately after breaking-in in current-clamp mode. Thereafter, currents were injected from −20 pA to +90 pA with 10-pA increments to induce action potentials. For sodium and potassium current measurements, cells were clamped at −70 mV and voltage-depolarizing steps were delivered for 100 ms at 10-mV increments. Spontaneous activity was measured in voltage-clamp mode using the same internal solution at resting membrane potentials. Group mean values were calculated using GraphPad Prism.

For details on cloning, virus production, immunohistochemistry, and quantifications, please see the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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![Ascl1, Lmx1a, and Nurr1 Efficiently Convert NG2 Glia into Neurons\
(A) Schematic of experimental procedures.\
(B) The syn-GFP reporter constructs are not expressed in NG2 glia.\
(C) Cre-inducible GFP reporter under the ubiquitously expressed promoter cba (green) co-labels with NG2 (red).\
(D--G) Converted cells appear after 1 week and increase in number and morphological maturity by 12 weeks.\
(H and I) NG2 glia can be converted into neurons by Ascl1 alone, albeit in lower numbers than when using ALN for conversion.\
Scale bars represent 50 μm in (C)--(F) and 10 μm in (D′)--(F′). A, Ascl1; L, Lmx1a; N, Nurr1. Error bars represent SEM. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![In-Vivo-Converted Neurons Express Pan-neuronal Markers and Downregulate NG2\
(A and B) NeuN (blue) is expressed in 20.8% ± 5.9% (n = 3) of re-programmed cells at 4 weeks after injection and 46.8% ± 2.9% (n = 3) of re-programmed cells at 12 weeks after injection.\
(C----D′′) Converted neurons co-express GFP (green), MAP2 (red), and NeuN (blue) (C--C′′′) but lose their NG2 expression (D--D′′).\
(E and F) The converted neurons express vGlut1 (red) (E) and GAD65/67 (red) (F).\
Scale bars represent 25 μm in (A)--(C′′′), 50 μm in (D)--(E), and 10 μm in (F). Error bars represent SEM. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Reprogrammed Neurons Show Electrophysiological Properties of Functional Neurons\
(A) Converted neurons acquire a mature neuronal morphology and exhibit dendrite spine-like protrusions.\
(B) Example of a cell selected for patch-clamp recordings 12 weeks after conversion.\
(C and D) Reprogrammed cells evoke action potentials (AP) upon depolarizing current injection (C) and inward sodium (Na^+^) and outward potassium (K^+^) current upon depolarization in artificial cerebrospinal fluid (ACSF) (D).\
(E) Action potentials and inward outward current could be blocked by adding the neurotoxin TTX to the buffer.\
(F) Examples of spontaneous post-synaptic currents.\
See also [Table S1](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Reprogrammed Neurons Are Innervated by the Pre-existing Local Neural Circuitry\
(A) Schematic of modified-rabies-mediated monosynaptic tracing. Reprogrammed cells infected by modified rabies appear with a green nucleus and a red cytoplasm, whereas any neuron providing synaptic input to the reprogrammed neurons appears as red only.\
(B) Experimental timeline.\
(C) Injection of unflexed tracer serves as positive methodological control. Targeted host neurons (green and red) receive synaptic input from local striatal neurons (red only).\
(D--F′) Traced neurons (DAB and red) are also detected in the motor cortex (PFC), thalamus (Thal), and substantia nigra (SN).\
(G) Tracing of reprogrammed neurons using FLEX tracer + ALN (red and green) shows traced host neurons (red).\
(H--J) The absence of traced neurons in PFC, Thal, and SN suggest that the reprogrammed cells integrate only locally.\
(K--K′′) Co-labeling of mCherry and DARRP32 (blue) shows that the traced neurons are of a medium spiny neuron subtype.\
(L) Distribution of the reprogrammed neurons (yellow) and traced neurons (red) in a representative animal.\
(M and N) Quantifications of reprogrammed (gray bars) and traced (white bars) neurons (n = 7).\
Scale bars represent 50 μm in (C) and (D′)--(G), 100 μm in (D)--(F) and (H)--(J), and 10 μm in (K)--(K′′). Error bars represent SEM. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}
